The aim of this study is to validate PLA2G7 as potential cancer selective biomarker, deepen our understanding on its molecular and cellular function and study the growth inhibitory potential of PLA2G7 impairment combined with statin exposure in cultured prostate cancer cells. This evidence concerns the gene PLA2G7 and prostate cancer.